The CNS as a therapeutic target in multiple sclerosis.
Antel
Jack P
JP
Montreal Neurological Institute, McGill University, Montreal, QC, Canada. jack.antel@mcgill.ca
D000818:Animals; D002490:Central Nervous System / Q000033:anatomy & histology / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D018450:Disease Progression; D006801:Humans; D007167:Immunotherapy; D009103:Multiple Sclerosis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012038:Regeneration / Q000502:physiology